Results
Table 1 presents the survey-weighted descriptive statistics of the study population. The endometriosis group was significantly older on average (41.04 vs. 39.21 years, P = 0.001) and had a higher proportion of non-Hispanic individuals (94.99% vs. 87.35%, P < 0.001). In terms of education, a greater percentage of endometriosis patients had completed high school or obtained a GED or equivalent (32.93% vs. 22.92%, P = 0.019). We acknowledge that there is a statistically significant age difference between the two groups (normal female group: 39.21 ± 9.32 years vs. endometriosis group: 41.04 ± 7.62 years, P = 0.001). Although the absolute age difference is relatively small (1.83 years), considering that age may potentially have an impact on the biological indicators of our study, we adjusted age as a covariate in all subsequent statistical analyses.
Table 1 Population characteristics of individuals in NHANES 2001–2006 ( n = 2,644). Normal female Endometriosis female
P
Age (mean (SD)) 39.21 (9.32) 41.04 (7.62)
0.001
Race (%)
< 0.001
Non-Hispanic 87.35 94.99 Hispanic 12.65 5.01 BMI (%) 0.998 Under weight 2.38 2.42 Normal weight 36.46 36.92 Over weight 26.69 26.26 Obesity 34.47 34.39 Smoker (%) 0.071 Never smoker 50.62 43.01 Former smoker 21.6 21.62 Current smoker 27.78 35.37 Alcohol (%) 0.487 No 17.54 19.45 Yes 82.46 80.55 Education (%)
0.019
High school and below 15.37 9.32 High school graduate/GED or equivalent 22.92 32.93 Some college or AA degree 36.64 34.76 College graduate or above 25.07 22.99 PIR (%) PIR ≤ 1 14.37 13.6 0.775 PIR 1–3 33.57 31.11 PIR > 3 52.06 55.29 Age of menarche (mean (SD)) 12.63 (1.61) 12.39 (1.76) 0.140 Number of pregnancies (mean (SD)) 3.00 (2.001) 2.81 (1.51) 0.089 Pregnancy (%) 0.051 No 93.36 97.19 Yes 6.64 2.81
Population characteristics of individuals in NHANES 2001–2006 ( n = 2,644).
Supplementary Table 1 presents the concentrations of PAEs, PAHs, And phytoestrogens. PAEs concentrations ranged from 0.90 ng/ml (MMP) to 139.39 ng/ml (MEP). PAHs levels varied widely, with 2-OHPHE at 55.86 ng/ml And 2-OHNAP at 3316.89 ng/ml. Among phytoestrogens, ENL had the highest median concentration at 370.14 ng/ml. Detailed levels of various metabolites are provided in Supplementary Table 1.
Logistic regression revealed significant associations between specific chemicals and endometriosis. ENL (OR: 0.828, 95% CI: 0.691, 0.991, P = 0.040) was found to be significantly negatively correlated with the presence of endometriosis, while seven PAHs, 1-OHNAP (OR: 1.238, 95% CI: 1.082, 1.418, P = 0.003), 2-OHNAP (OR: 1.409, 95% CI: 1.053, 1.884, P = 0.022), 3-OHFLU (OR: 1.352, 95% CI: 1.050, 1.742, P = 0.021), 2-OHFLU (OR: 1.407, 95% CI: 1.029, 1.924, P = 0.033), 3-OHPHE (OR: 1.426, 95% CI: 1.045, 1.944, P = 0.026), 1-OHPHE (OR: 1.679, 95% CI: 1.153, 2.446, P = 0.008) And 2-OHPHE (OR: 1.529, 95% CI: 1.133, 2.062, P = 0.006), along with MBzP (OR: 1.354, 95% CI: 1.096, 1.673, P = 0.006), were positively associated with the condition (Fig. 2 A, Supplementary Table 2).
PLS-DA further validated the results from logistic regression (except for MBzP) and confirmed the potential association between identified PAHs and phytoestrogens with endometriosis (Fig. 2 A, Supplementary Table 2).
The WQS model was used to estimate the combined effect of mixed EDC exposures on the risk of endometriosis. In the model, it is important to note that in the negative direction, O-DMA, MMP, MEP, 1-OHPYR, END, Daidzein, ENL and MEHP exhibited a higher Weight, while MEP, 1-OHPHE, MBzP, 2-OHFLU And 3-OHFLU showed a higher weight in the positive direction (Fig. 2 B-C).
In quantile g-computation model, GNS, MBzP, 1-OHPHE, 1-OHNAP, MEHHP, 2-OHNAP, And MCPP were identified as positive contributors to the quantile g-computation scores, while 1-OHPYR, MEOHP, Daidzein, MEHP, ENL, END, and MMP were identified as negative contributors to the quantile g-computation scores in estimating the endometriosis risk for each EDC (Fig. 2 D). The Venn diagram demonstrated that the combination of logistic regression with PLS-DA, WQS, And quantile g-computation consistently identified 1-OHPHE and ENL, a gut microbiota-derived metabolite from phytoestrogens, as the key exposures associated with endometriosis (Fig. 2 E).
Fig. 2 Associations between EDCs exposure and endometriosis risk. (A) Association analysis of EDCs exposure and endometriosis risks: Logistic regression and PLS-DA. (B) Positive WQS regression weights between EDCs exposure and endometriosis risks; (C) Negative WQS regression weights between EDCs exposure and endometriosis risks. (D) Quantile g-computation model regression index weights of the mixture on endometriosis risk. (E) Key EDCs associated with endometriosis identified through various statistical model. PAEs Phthalates PAHs Polycyclic aromatic hydrocarbons PLS-DA partial least squares discriminant analysis WQS weighted quantile sum 1-OHPHE 1-Hydroxyphenanthrene ENL enterolactone.
Associations between EDCs exposure and endometriosis risk. (A) Association analysis of EDCs exposure and endometriosis risks: Logistic regression and PLS-DA. (B) Positive WQS regression weights between EDCs exposure and endometriosis risks; (C) Negative WQS regression weights between EDCs exposure and endometriosis risks. (D) Quantile g-computation model regression index weights of the mixture on endometriosis risk. (E) Key EDCs associated with endometriosis identified through various statistical model. PAEs Phthalates PAHs Polycyclic aromatic hydrocarbons PLS-DA partial least squares discriminant analysis WQS weighted quantile sum 1-OHPHE 1-Hydroxyphenanthrene ENL enterolactone.
We examined the relationship between inflammatory markers (CRP, Fer, UA) and lipid biomarkers (HDL-C, LDL-C, TC, TG) with endometriosis risk. Logistic regression analysis indicated that higher Fer levels significantly associated with increased the risk of endometriosis (OR: 1.599, 95% CI: 1.306, 1.957, P < 0.001), as did TG (OR: 1.880, 95% CI: 1.251, 2.826, P = 0.003) and UA (OR: 1.803, 95% CI: 1.005, 3.232, P = 0.048) (Fig. 3 A, Supplementary Table 3). In the PLS-DA model, Fer and UA showed positive correlations with endometriosis risk, while TG was not significantly associated (Fig. 3 A, Supplementary Table 3).
As shown in Supplementary Table 4, Linear regression analysis revealed several significant associations between EDCs and Lipid And inflammatory biomarkers. HDL-C was positively correlated with MMP, O-DMA, ENL And END, but negatively correlated with 2-OHFLU, 2-OHNAP, 2-OHPHE, 3-OHFLU And 3-OHPHE. EQU was positively correlated with TC And LDL-C. TG showed a negative correlation with O-DMA And ENL, And a positive correlation with 2-OHPHE, 2-OHNAP, 1-OHPHE, And 1-OHPYR. Fer was negatively correlated with MEHP And GNS, but positively correlated with 1-OHPHE. CRP was positively correlated with 2-OHPHE And MBzP, And negatively correlated with MMP, Daidzein, O-DMA, ENL, EQU, And GNS. UA was negatively correlated with MEHP, MMP, ENL, and 1-OHNAP (Fig. 3 B).
In the PLS-DA model, HDL-C remained significantly correlated with 2-OHFLU, 2-OHNAP, 3-OHFLU, MMP, ENL And END; EQU remained significantly correlated with TC And LDL-C; TG remained significantly correlated with ENL, 1-OHPHE, 2-OHPHE And 1-OHPYR; Fer remained significantly correlated with MEHP And 1-OHPHE; CRP remained significantly correlated with 2-OHPHE and ENL; and UA remained significantly correlated with ENL (Fig. 3 B).
Based on the results from Sect. 3.3 And 3.5 to 3.6, we explored potential mediating pathways through which inflammatory factors may link phytoestrogens and PAHs exposures with endometriosis. We conducted pairwise regression analyses to examine the associations between: (1) EDCs and inflammatory biomarkers (linear regression), and (2) EDCs/inflammatory biomarkers and endometriosis (logistic regression).
These Analyses revealed potential indirect pathways consistent with mediation. Specifically, ENL showed inverse associations with both UA levels And endometriosis prevalence, while UA was positively associated with endometriosis, suggesting a potential pathway where ENL may be associated with reduced endometriosis prevalence through its association with lower UA levels. Similarly, 1-OHPHE demonstrated positive associations with both Fer levels and endometriosis prevalence, while elevated Fer was associated with increased endometriosis prevalence, indicating a potential pathway Linking 1-OHPHE exposure to endometriosis through inflammatory processes (Fig. 3 C).
Fig. 3 Associations between biomarkers, EDCs exposure, and endometriosis risk: Statistical analyses and mediation associations. (A) Association analysis of lipid metabolism, inflammatory biomarkers and endometriosis: Logistic regression and PLS-DA. (B) Association analysis of EDCs and lipid metabolism, inflammatory biomarkers: Linear regression and PLS-DA. (C) Mediation analysis of the associations between of PAHs and phytoestrogens on the risk of endometriosis. CRP C-reactive protein Fer ferritin HDL-C high-density lipoprotein cholesterol LDL-C low-density lipoprotein cholesterol TC total cholesterol TG triglycerides UA uric acid 1-OHPHE 1-Hydroxyphenanthrene ENL enterolactone.
Associations between biomarkers, EDCs exposure, and endometriosis risk: Statistical analyses and mediation associations. (A) Association analysis of lipid metabolism, inflammatory biomarkers and endometriosis: Logistic regression and PLS-DA. (B) Association analysis of EDCs and lipid metabolism, inflammatory biomarkers: Linear regression and PLS-DA. (C) Mediation analysis of the associations between of PAHs and phytoestrogens on the risk of endometriosis. CRP C-reactive protein Fer ferritin HDL-C high-density lipoprotein cholesterol LDL-C low-density lipoprotein cholesterol TC total cholesterol TG triglycerides UA uric acid 1-OHPHE 1-Hydroxyphenanthrene ENL enterolactone.
Building on the significant findings from the logistic regression and PLS-DA analysis, we further investigated the relationship between log-transformed urine levels of significant chemical substances and endometriosis risk using RCS (Fig. 4 A-B).
Subgroup Analyses were conducted to examine the influence of various covariates on the relationship between urinary ENL, 1-OHPHE, and endometriosis risk (Supplementary Tables 5–6). Based on the results from both the logistic regression And PLS-DA models, we found that urinary ENL levels were significantly negatively correlated with endometriosis risk in participants who were obese, not pregnant, And had fewer than three pregnancies. For 1-OHPHE, a significant positive correlation with endometriosis risk was observed in individuals who were under 35 years old, non-Hispanic, consumed alcohol, had lower educational attainment, had lower socioeconomic status, and had either been pregnant or not pregnant, as well as those with three or more pregnancies. Additional subgroup analyses are presented in Supplementary Fig. S1 .
Fig. 4 Dose-response And subgroup Analysis of ENL And 1-OHPHE exposure on endometriosis risk. (A-B) Dose-response relationships between log-transformed urinary ENL ( A ) And 1-OHPHE ( B ) levels And endometriosis risk, with the shaded area representing the 95% confidence interval. 1-OHPHE 1-Hydroxyphenanthrene ENL enterolactone OR Odds ratios CI confidence intervals.
Dose-response And subgroup Analysis of ENL And 1-OHPHE exposure on endometriosis risk. (A-B) Dose-response relationships between log-transformed urinary ENL ( A ) And 1-OHPHE ( B ) levels And endometriosis risk, with the shaded area representing the 95% confidence interval. 1-OHPHE 1-Hydroxyphenanthrene ENL enterolactone OR Odds ratios CI confidence intervals.
To explore the underlying mechanisms of ENL in endometriosis, we predicted potential target genes for both ENL And endometriosis using SuperPred, SwissTargetPrediction, And GeneCards. A Venn diagram, generated by intersecting the ENL targets with 2,465 endometriosis-related protein coding targets, revealed 65 common targets (Fig. 5 A). Subsequently, a subsequent PPI network was constructed using STRING And visualized with Cytoscape 3.10.2. After excluding isolated targets, the final PPI network highlighted several critical interactions (Fig. 5 C-D), with ESR1 showing the highest degree centrality. Notably, XDH, considered a key player in the purine metabolism pathway, particularly in UA production, is also present in this PPI network. For PAHs, target prediction for 1-OHPHE identified 133 targets using SuperPred And SwissTargetPrediction. After cross-referencing with GeneCards, 43 targets were selected (Fig. 5 B). PPI network analysis revealed GRB2 as the most prominent target, exhibiting the highest degree value (Fig. 5 E-F).
Fig. 5 Identification of common targets And interaction networks between ENL, 1-OHPHE, and endometriosis. (A) Venn diagram of common targets between ENL and endometriosis. (B) Venn diagram of common targets between 1-OHPHE and endometriosis. (C-D) PPI network for ENL and endometriosis targets. (E-F) PPI network for 1-OHPHE and endometriosis targets. 1-OHPHE 1-Hydroxyphenanthrene ENL enterolactone.
Identification of common targets And interaction networks between ENL, 1-OHPHE, and endometriosis. (A) Venn diagram of common targets between ENL and endometriosis. (B) Venn diagram of common targets between 1-OHPHE and endometriosis. (C-D) PPI network for ENL and endometriosis targets. (E-F) PPI network for 1-OHPHE and endometriosis targets. 1-OHPHE 1-Hydroxyphenanthrene ENL enterolactone.
To explore the potential biological pathways And functions of ENL And 1-OHPHE in endometriosis, we performed GO And KEGG enrichment Analyses using the R package clusterProfiler on 65 common targets for ENL And 43 common targets for 1-OHPHE (Fig. 5 A).
KEGG pathway analysis for ENL targets (Fig. 6 A) revealed enrichment in pathways such as prostate cancer, endocrine resistance, breast cancer, central carbon metabolism in cancer, and EGFR tyrosine kinase inhibitor resistance. GO enrichment analysis (Fig. 6 B) identified several key biological processes, including regulation of MAPK activity, cellular response to chemical stress, cellular response to oxidative stress, positive regulation of MAPK activity, and regulation of reactive oxygen species metabolism.
For 1-OHPHE targets, KEGG pathway analysis (Fig. 6 C) highlighted significant pathways such as prostate cancer, Ras signaling pathway, acute myeloid leukemia, PI3K-Akt signaling pathway, and chronic myeloid leukemia. GO enrichment analysis (Fig. 6 D) revealed enriched processes primarily related to response to lipopolysaccharide, response to molecules of bacterial origin, peptidyl-tyrosine phosphorylation, peptidyl-tyrosine modification, and cell chemotaxis.
For ESR1, it was found to be involved in the top 20 KEGG pathways, including endocrine resistance, breast cancer, prolactin signaling pathway, PI3K-Akt signaling pathway, And chemical carcinogenesis-receptor activation. The top 20 GO pathways for ESR1 included regulation of protein kinase B, kinase B signaling, positive regulation of kinase B signaling, regulation of inflammatory response, and gland development. GRB2, meanwhile, was involved in the top 20 KEGG pathways, such as prostate cancer, Ras signaling pathway, acute myeloid leukemia, PI3K-Akt signaling pathway, Human cytomegalovirus infection, focal adhesion, proteoglycans in cancer, MAPK signaling pathway, microRNAs in cancer, EGFR tyrosine kinase inhibitor resistance, chemical carcinogenesis-reactive oxygen species, And Human papillomavirus infection. Additionally, aging was enriched in the top 20 GO pathways for GRB2. We found that both ESR1 and GBR2 shared the PI3K-Akt signaling pathway (Fig. 6 E).
To explore the potential binding interactions of ENL with key target proteins identified through network analysis, molecular docking simulations were performed with ESR1 and XDH. The results, shown in Fig. 6 F-G, revealed binding energies of −9.8 kcal/mol for the ENL-ESR1 complex and − 8.1 kcal/mol for the ENL-XDH complex, indicating strong binding affinities of ENL for both proteins. Specifically, ENL interacted with ESR1 by forming conventional hydrogen bonds with THR347 and LEU387, π-π T-shaped interactions with PHE404, alkyl interactions with LEU346 and ALA350, and π-alkyl interactions with LEU346, ALA350, LEU391, LEU525, and LEU384. In the ENL-XDH complex, ENL formed conventional hydrogen bonds with SER347 and GLY350, a carbon-hydrogen bond with GLY349, and π-donor hydrogen bonds with ASN261 and VAL259 (Fig. 6 G), Therefore, the electron transfer of Molybdenum Cofactor (Moco), [2Fe-2 S] and Flavin adenine dinucleotide (FAD) in the process of enzyme catalysis for UA production was blocked 44 . Additionally, ENL established alkyl interactions with LEU257 and ILE353, and π-alkyl interactions with ILE264. These findings suggest that ENL binds effectively to both ESR1 and XDH, supporting the hypothesis that ENL may mitigate endometriosis by modulating ESR1 activity and inhibiting XDH-mediated UA production.
To further investigate the binding interactions of 1-OHPHE with the key target GRB2, additional molecular docking simulations were conducted. As shown in Fig. 6 H, the binding energy for the 1-OHPHE-GRB2 complex was − 6.1 kcal/mol, indicating stable binding affinity. Specifically, 1-OHPHE formed π-π T-shaped interactions with PHE125.
As mediation analysis revealed that UA mediates the relationship between ENL and decreased risk (Fig. 3 C), in the above targets, considering that XDH is An upstream target that directly produces UA, we selected the ENL-XDH complex for molecular dynamics simulation within 100 ns under simulated water environment. The root mean square deviation (RMSD) of the protein-ligand complex during the simulation (Fig. 6 I) remained stable at approximately 0.1 nm, indicating that the ENL-XDH complex maintained a consistent and stable conformation throughout the simulation period. Additionally, the root mean square fluctuation (RMSF) analysis revealed that residues near the active site of XDH showed reduced fluctuation and stabilized after the binding of ENL to the enzyme (Fig. 6 J). These findings suggest that ENL binding may influence the conformation of the active site, potentially modulating the enzymatic function of XDH by occupying the FAD site in the normal catalytic process (Fig. 6 K).
Fig. 6 Target identification And molecular interactions of ENL And 1-OHPHE in endometriosis. (A) KEGG enrichment analysis of biological processes for ENL targets in endometriosis. (B) GO pathway analysis of ENL targets in endometriosis. (C) KEGG enrichment Analysis of biological processes for 1-OHPHE targets in endometriosis. (D) GO pathway Analysis of 1-OHPHE targets in endometriosis. (E) Intersection of KEGG and GO enrichment results for ESR1 and GRB2. (F-G) Molecular docking analysis of ENL binding to ESR1 and XDH complexes. (H) Molecular docking Analysis of 1-OHPHE binding to GRB2 complexes. (I) RMSD from molecular dynamics simulations of XDH and ENL. (J) RMSF from molecular dynamics simulations of XDH with ENL. The red boxes highlight the pathways among the top 20 enriched pathways that involve ESR1 and GRB2, while the green squares indicate the pathways that are shared by both. (K) Overview of XDH catalytic mechanism in oxidizing hypoxanthine to xanthine, and xanthine to UA via Moco, [2Fe-2 S], and FAD. ENL blocks the electron transfer of Moco, [2Fe-2 S], and FAD in the enzymatic process by binding to the FAD site. RMSD root mean square deviation RMSF root mean square fluctuation ENL enterolactone UA uric acid FAD Flavin adenine dinucleotide Moco Molybdenum Cofactor.
Target identification And molecular interactions of ENL And 1-OHPHE in endometriosis. (A) KEGG enrichment analysis of biological processes for ENL targets in endometriosis. (B) GO pathway analysis of ENL targets in endometriosis. (C) KEGG enrichment Analysis of biological processes for 1-OHPHE targets in endometriosis. (D) GO pathway Analysis of 1-OHPHE targets in endometriosis. (E) Intersection of KEGG and GO enrichment results for ESR1 and GRB2. (F-G) Molecular docking analysis of ENL binding to ESR1 and XDH complexes. (H) Molecular docking Analysis of 1-OHPHE binding to GRB2 complexes. (I) RMSD from molecular dynamics simulations of XDH and ENL. (J) RMSF from molecular dynamics simulations of XDH with ENL. The red boxes highlight the pathways among the top 20 enriched pathways that involve ESR1 and GRB2, while the green squares indicate the pathways that are shared by both. (K) Overview of XDH catalytic mechanism in oxidizing hypoxanthine to xanthine, and xanthine to UA via Moco, [2Fe-2 S], and FAD. ENL blocks the electron transfer of Moco, [2Fe-2 S], and FAD in the enzymatic process by binding to the FAD site. RMSD root mean square deviation RMSF root mean square fluctuation ENL enterolactone UA uric acid FAD Flavin adenine dinucleotide Moco Molybdenum Cofactor.
Given ENL’s potential protective role, we further investigated its impact on PAHs exposure. To explore potential intervention strategies for PAHs-related endometriosis risk, we analyzed the effect of serum ENL levels (categorized by median) on the relationship between PAHs And endometriosis risk. Supplementary Table 7 shows that, for individuals with low ENL levels, PAHs such as 1-OHNAP, 1-OHPHE, 2-OHFLU, 2-OHNAP, 2-OHPHE, 3-OHFLU, 3-OHPHE were positively associated with endometriosis risk. In contrast, for individuals with high ENL levels, these positive associations were no longer observed, suggesting that ENL may mitigate the harmful effects of PAHs on endometriosis risk. Since ENL is a ligand-derived metabolite produced by the gut microbiota, the results suggest that the gut microbiota play a role in this protective effect.
To investigate the underlying mechanisms, we examined the shared targets of ENL And 1-OHPHE and found that ESR1 (target of ENL) and GRB2 (target of 1-OHPHE) both co-participate in the PI3K-Akt (kinase B) signaling pathway. The activation of PI3K-Akt signaling is promoted by ESR1 translocation from the nucleus to the plasma membrane, while GRB2 facilitates PI3K recruitment and activation via its interaction with Gab1, thereby initiating the PI3K-Akt pathway and regulating cell survival and proliferation 45 – 47 . This suggested that 1-OHPHE and ENL exerted their potential role by interfering with PI3K-Akt signaling pathway.
Discussion
In this cross-sectional study of American women, the results indicated that the phytoestrogen ENL was negatively associated with endometriosis risk, whereas the PAH metabolite 1-OHPHE was consistently positively associated with the risk under mixed exposure. The subgroup Analysis identified the potentially susceptible populations. Mediation Analysis suggests that UA And Fer may mediate the association of ENL and 1-OHPHE with endometriosis, respectively. Molecular docking analysis indicated that ENL may reduce the risk of endometriosis by binding to ESR1 And XDH. In contrast, 1-OHPHE may increase the risk by interacting with GRB2. Through molecular dynamics simulation of XDH, a direct catalytic target of UA, we found that ENL may inhibit UA production by occupying the FAD site of XDH. The supplementation with ENL may represent a viable strategy to mitigate the adverse effects of certain PAHs exposure on the risk of endometriosis.
Phytoestrogens refer to a class of plant-derived compounds that exhibit estrogen-like effects. They have been widely studied for their ability to interact with estrogen receptors, particularly for their potential therapeutic role in endometriosis. Previous studies suggest that phytoestrogens may help manage endometriosis symptoms by regulating estrogen levels, inhibiting cell proliferation, modulating hormone signaling pathways, and controlling inflammation 48 . Additionally, epidemiological studies have found that phytoestrogens may offer protective effects against the development of endometriosis, as they are closely related to the regulation of hormone levels, immune markers, and inflammatory indicators, showing a negative correlation with endometriosis risk 49 . However, the involvement of specific phytoestrogen metabolites in endometriosis among humans under mixed exposure remains unknown. Notably, phytoestrogen metabolites like ENL and END have been identified as phytoestrogens with weak estrogenic activity, as well as anti-estrogenic properties. Studies indicate that these anti-estrogenic effects may contribute to breast cancer prevention 50 . Our research also suggests that phytoestrogen ENL may have potential in reducing the risk of endometriosis. Phytoestrogens typically enter the body in their native form, but their bioactivity is largely dependent on the metabolic actions of the gut microbiota. The gut microbiota can convert phytoestrogens into various active metabolites, thereby influencing their physiological effects on the host 51 . The composition and diversity of the gut microbiota directly impact the metabolism of phytoestrogens and their biological effects. Individual differences in gut microbiota may lead to variability in the biological effects of phytoestrogens, as different microbiota may metabolize phytoestrogens differently 52 . ENL is a metabolite formed from lignans through the action of gut microbiota 53 . Dysbiosis in the gut microbiota may reduce the metabolic efficiency of lignans, thereby affecting the production and bioavailability of ENL. Therefore, the health status and diversity of the gut microbiota are critical for the proper biological function of ENL, directly influencing its generation and biological effects.
In contrast to the potential protective effects of phytoestrogens, PAHs, known endocrine disruptors, are positively correlated with the risk of endometriosis. PAHs are commonly found in air pollution, cigarette smoke, and charred food, and they can mimic or block the action of natural hormones, disrupting the endocrine system. This can lead to hormone imbalance, promote abnormal tissue growth, and trigger inflammatory responses, thereby increasing the risk of endometriosis. One study found that the accumulation levels of PAHs in the abdominal adipose tissue of patients with endometriosis were significantly higher 54 . PAHs may exacerbate the risk of endometriosis by promoting chronic inflammation, oxidative stress, and hormone imbalance 55 .
This study found a negative correlation between ENL And UA, And a positive correlation between 1-OHPHE and Fer. Moreover, both UA and Fer levels were positively correlated with the risk of endometriosis. A previous study showed that phytoestrogens could reduce UA production 56 and experimental studies demonstrated that exposure to PAHs in rainbow trout increased Fer levels 57 . Previous research also indicated that elevated levels of Fer and UA might serve as risk biomarkers for endometriosis 58 , 59 . Research has shown that the expression of Fer confers resistance to apoptosis in endometriosis cells 60 .
Additionally, the construction of 1-OHPHE, ENL and endometriosis targets network provided insights into the potential protective mechanisms of phytoestrogens in endometriosis. We found that ENL can bind stably to the FAD active site of XDH, which plays a key role in electron transfer for UA production, suggesting that ENL may reduce UA levels and alleviate inflammation by inhibiting XDH activity, thereby reducing the risk of endometriosis. ENL also binds to the ESR1 receptor, disrupting its normal function. Estrogen regulates the growth, proliferation, and shedding of the endometrial tissue by binding to the ESR1 receptor 61 . ESR1 promotes the proliferation of endometrial epithelial cells through PI3K-Akt pathways, a process that has been validated in mouse models 62 . Furthermore, studies indicate that compared to the control group, ESR1 levels in the secretory-phase endometrium of women with endometriosis are significantly elevated 63 . Therefore, the binding of ENL to ESR1 may affect the function of ESR1 in endometriosis. Further Analysis of the harmful effects of PAHs revealed that their metabolites, 1-OHPHE, can bind to GRB2 and interfere with its normal function. GRB2 promotes the recruitment and activation of PI3K, triggering the PI3K-Akt pathway and modulating cell survival and proliferation. Previous studies have shown that GRB2 plays an essential role in the molecular mechanisms underlying endometriosis 64 . The main components of PI3K-Akt pathway are PI3K and Akt/protein kinase B, which, upon activation, inhibit apoptosis and promote cell survival 65 . Continuous activation of PI3K-Akt signaling pathway may lead to chronic inflammation and tissue damage 66 , 67 . Previous studies have shown that the PI3K/Akt signaling pathway is activated in patients with endometriosis, accompanied by an increase in pyroptosis and inflammatory cytokine levels 68 . Additionally, small molecule inhibitors of the PI3K-Akt pathway have demonstrated therapeutic efficacy in mouse models 69 . Some research shows that PI3K-Akt inhibitor reduced UA by inhibiting the expression of uric acid metabolizing proteins, reducing inflammation, oxidative stress, and mitochondrial apoptosis 70 , 71 . Studies have shown that the expression of XDH can activate several immune-related signaling pathways, including the PI3K-AKT pathway, thereby inducing cytotoxic immune responses 72 . Meanwhile, one study showed that chemical induced increased ferritin levels, which was mediated by the Akt pathway 73 . Other research has shown that the degradation of Fer (called ferritinophagy) is closely related to the PI3K-AKT pathway. Therefore, exposure to ENL And 1-OHPHE may alter UA and Fer levels, respectively, by interfering with the PI3K-Akt signaling pathway, potentially modulating the risk of endometriosis. The mechanism described in this study is illustrated in Fig. 7 .
This study offers several key strengths. Firstly, it utilized a large, nationally representative sample, enhancing both the external validity And statistical power of the findings. Additionally, the study controlled for a range of potential confounders, which helps to reduce bias And confounding in the Analysis. Furthermore, various stratified and sensitivity analyses and distinct statistical approaches, such as WQS and quantile g-computation, were employed to evaluate the combined effects of EDC mixtures on the risk of endometriosis, providing complementary insights and reinforcing the robustness of the results. Additionally, we identified the mediating roles of UA and Fer in the relationships between ENL and 1-OHPHE exposure and the risk of endometriosis, which contributes to a more comprehensive understanding of the harmful effects of EDCs. The other strength of the study was the use of network pharmacology analysis to explore the potential mechanisms underlying the effects of EDCs. Moreover, we found that ENL supplementation could be a promising strategy to mitigate the adverse impacts of PAH exposure on endometriosis risk.
However, the study has some Limitations. First, as a cross-sectional design, it is not possible to draw causal conclusions about the relationship between EDCs and the risk of endometriosis. Future prospective cohort studies with longitudinal follow-up would be valuable to establish temporal relationships and strengthen causal inference between EDC exposure And endometriosis development. Second, the use of single-point urinary samples from NHANES makes it difficult to accurately assess long-term exposure to EDCs, and 24-hour urine samples would likely provide more reliable results. Future studies should consider implementing repeated biomonitoring over multiple time points or using alternative biomarkers with longer half-lives to better capture chronic exposure patterns. Additionally, incorporating personal exposure monitoring devices could provide more comprehensive exposure assessments. However, although the risk of misclassification may still exist, it is most likely non-differential and would therefore primarily attenuate the observed exposure–effect associations 74 . Third, due to the lack of information on exposure to lignans, we were unable to further investigate the role of gut microbiota in influencing the effects of phytoestrogens on endometriosis through the metabolic relationship between gut microbiota, lignans, and ENL. Future research should integrate microbiome analysis with phytoestrogen metabolite profiling to elucidate the complex interplay between gut microbiota, dietary phytoestrogens, and endometriosis risk. Fourth, the study lacks histological or surgical confirmation of endometriosis cases, relying instead on self-reported diagnosis from NHANES questionnaires. This may introduce misclassification bias, as gold standard endometriosis diagnosis requires laparoscopic confirmation. Our study employed various statistical methods and mechanistic analyses as complementary approaches to the observational data in order to improve the reliability of the results. Future research should incorporate clinically validated endometriosis diagnoses to strengthen the reliability of environmental exposure associations.
Fig. 7 Mechanisms underlying the role of enterolactone and 1-hydroxyphenanthrene in endometriosis development. 1-OHPHE 1-Hydroxyphenanthrene.
Mechanisms underlying the role of enterolactone and 1-hydroxyphenanthrene in endometriosis development. 1-OHPHE 1-Hydroxyphenanthrene.